GlaxoSmithKline Plc ADR (GSK)


GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. Its principal pharmaceutical products include medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, oncology and emesis, dermatalogicals and vaccines. The Company's segments include Pharmaceuticals and Consumer Healthcare.

View SEC Filings from GSK instead.
Filers who had this stock in their top 10: 10
13F Filers holding this stock: 728
Aggregate shares on 06/30/2016: 215,991,224
Aggregate shares on 03/31/2016: 205,611,102
Percent change: 5.05%
Funds creating new positions: 69
Funds Adding to an existing position: 278
Funds closing out their position: 46
Funds reducing their position: 253

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Schedule 13D and 13G filings submitted since 06/30/2016

Subscription required

Click here to report any possible errors with this stock listing.

Elevate your investments

or Learn more